# Hologic to acquire Cynosure for $1.65 billion

Hologic has signed a definitive agreement to acquire all outstanding shares of Cynosure for $66.00 per share in cash, corresponding to an equity value of approximately $1.65 billion and an enterprise value of $1.44 billion net of cash.

- Type: Acquisition
- Announced: 2017-02-14
- Where: United States
- Value: $1.65B
- Status: announced
- Products: medical aesthetics systems and technologies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Hologic](https://endata.com/companies/22178.md) (acquirer)
- [Cynosure](https://endata.com/companies/22179.md) (target)

## Sources

- [sec.gov](https://www.sec.gov/Archives/edgar/data/885306/000119312517043608/d276853dex991.htm), 2017-02-14: "Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses"
- [biospace.com](https://www.biospace.com/hologic-takes-out-cynosure-in-1-65-billion-deal), 2017-02-14: "Hologic, Inc. and Cynosure, Inc. announced today they have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash."
- [prnewswire.com](https://www.prnewswire.com/news-releases/hologic-completes-acquisition-of-cynosure-300427695.html), 2017-03-22: "We are pleased to complete our acquisition of Cynosure, and look forward to working with Michael Davin and the entire Cynosure team to achieve even greater success in the large, rapidly growing medical aesthetics market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.